Possible underlying influence of p38MAPK and NF-κB in the diminished anti-anxiety effect of diazepam in stressed mice

Journal of Pharmacological Sciences

Volumn 116, Issue 3, 2011, Pages 257-263

  Sharma, Vipin ^a   Gilhotra, Ritu ^a   Dhingra, Dinesh ^b   Gilhotra, Neeraj ^c  

^a SURESH GYAN VIHAR UNIVERSITY   (India)

^b GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^c MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

Anxiety; Diazepam; Immobilization; Pyrrolidine dithiocarbamate (PDTC); SB 203580

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DIAZEPAM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRITE; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; IMMOBILIZATION STRESS; LOCOMOTION; MALE; MAZE TEST; MONOTHERAPY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; TRANQUILIZING ACTIVITY;

EID: 79960410542     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11026FP     Document Type: Article

References (53)

1. Esch T, Stefano GB, Fricchione GL, Benson H. The role of stress in neurodegenerative diseases and mental disorders. Neuro Endocrinol Lett. 2002;23:199-208. (Pubitemid 34741927)
2. Masood A, Banerjee B, Vijayan VK, Ray A. Modulation of stress-induced neurobehavioral changes by nitric oxide in rats. Eur J Pharmacol. 2003;458:135-139. (Pubitemid 36050711)
3. Tsuchiya T, Kishimoto J, Koyama J, Ozawa T. Modulatory effect of L-NAME, a specific nitric oxide synthase (NOS) inhibitor, on stress-induced changes in plasma adrenocorticotropic hormone and corticosterone levels in rats: physiological significance of stress-induced NOS activation in hypothalamic-pituitary-adrenal axis. Brain Res. 1997;776:68-74. (Pubitemid 28018459)
4. Madrigal JLM, Olivia HO, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, et al. The increase in TNF-α Levels is implicated in NF-κB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology. 2002;26:155-163.
5. Sevgi S, Ozek M, Eroglu L. L-NAME prevent anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods Find Exp Clin Pharmacol. 2006;28:95-99.
6. Goyal R, Kumar A. Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice. Pharmacol Rep. 2007;59:284-290. (Pubitemid 47299729)
7. Gilhotra N, Dhingra D. Involvement of NO-cGMP pathway in anti-anxiety effect of aminoguanidine in stressed mice. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1502-1507.
8. Gilhotra N, Dhingra D. GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice. Brain Res. 2010;1352:167-175.
9. Bogoyevitch AM. Signaling via stress-activated mitogen-activated protein kinase in the cardiovascular system. Cardiovascular Res. 2000;45:826-842.
10. Lahti A, Sareila O, Kankaanranta H, Moilanen E. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression. BMC Pharmacol. 2006;6:5.
11. Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochem Biophys Acta. 2007;1773:1358-1375. (Pubitemid 47125981)
12. Chen CC, Wang JK. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol. 1999;55:481-488.
13. Xu X, Malave A. p38 but not p42/p44 MAPK mediated inducible nitric oxide synthase expression in C6 glioma cells. Life Sci. 2000;67:3221-3230.
14. Won JS, Lee JK, Suh HW. Forskolin inhibit expression of inducible nitric oxide synthase mRNA via inhibiting the mitogen activated protein kinase in C6 cells. Mol Brain Res. 2001;89:1-10.
15. Madrigal JL, Moro MA, Lizasaoin I, Lorenzo P, Castrillo A, Bosca L, et al. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem. 2001;76:532-538. (Pubitemid 32097029)
16. Zie QW, Kashiwabara Y, Nathan C. Role of NFkB/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705-4708.
17. Weizman AM, Bidder FF, Gavish M. Food deprivation modulates gamma-butyric acid receptors and peripheral benzodiazepine binding sites in rats. Brain Res. 1990;535:96-100.
18. Sun AY, Li DX, Wang YL. Stress-induced changes of central GABAergic function in rats. Zhongguo Yao Li Xue Bao. 1991; 12:387-390.
19. Boix F, Fernandez TA, Tobea A. The anxiolytic action of benzodiazepines is not present in handling-habituated rats. Pharmacol Biochem Behav. 1988;31:541-546. (Pubitemid 19274246)
20. Snyder SH, Bredt DS. Nitric oxide as a neural messenger. Trends Pharmacol Sci. 1991;12:125-128.
21. Nagao K, Takenaka S, Yamaji R, Inui H, Nakano Y. Nitric oxide synthase induction, cGMP elevation, and biopterin synthesis in vascular smooth muscle cells stimulated with interleukin-1beta in hypoxia. J Biochem. 2003;133:501-505. (Pubitemid 36604696)
22. Zarri I, Bucossi G, Cupello A, Rapallino MV, Robello M. Modulation by nitric oxide of rat brain GABAA receptors. Neurosci Lett. 1994;180:239-242.
23. Robello M, Amico C, Bucossi G, Cupello A, Rapallino MV, Thellung S. Nitric oxide and GABAA receptor function in the rat cerebral cortex and cerebellar granule cells. Neuroscience. 1996; 74:99-105.
24. Wexler EM, Stanton PK, Nawy S. Nitric oxide depresses GABAA receptor function via coactivation of cGMP-dependent kinase and phosphodiesterase. J Neurosci. 1998;18:2342-2349.
25. Gilhotra N, Jain H, Dhingra D. Differential effects of nitric oxide synthase inhibitors on anxiety in unstressed and stressed mice. Ind J Exp Biol. 2010;48:365-372.
26. Kulkarni SK. Handbook of experimental pharmacology, 3rd ed. Delhi: Vallabh Prakashan; 1999.
27. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980;13:167-170. (Pubitemid 11225713)
28. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnock JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Annal Biochem. 1982;126:131-138. (Pubitemid 13203451)
29. Calatayud F, Belzung C, Aubert A. Ethological validation and the assessment of anxiety-like behaviours: methodological comparison of classical analyses and structural approaches. Behav Processes. 2004;67:195-206. (Pubitemid 38881474)
30. Kumari B, Kumar A, Dhir A. Protective effect of non-selective and selective COX-2-inhibitors in acute immobilization stressinduced behavioral and biochemical alterations. Pharmacol Rep. 2007;59:699-707. (Pubitemid 351586561)
31. Bhattacharya SK, Bhattachatyya D. Effect of restraint stress on rat brain serotonin. J Biosci. 1982;4:269-274.
32. Belzung C, Griebel G. Measuring normal and pathological anxiety- like behaviour in mice: a review. Behav Brain Res. 2001; 125:141-149. (Pubitemid 33000452)
33. Lee CY, Cheng HM, Sim SM. Mulberry leaves protect rat tissues from immobilization stress-induced inflammation. Biofactors. 2007;31:25-33. (Pubitemid 352032103)
34. Fiore M, Alleva E, Probert L, Kollias G, Angelucci F, Aloe L. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha. Physiol Behav. 1998; 63:571-576. (Pubitemid 28119191)
35. Kumar A, Singh A. Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep deprivation- induced behavioral alterations and oxidative damage in mice. Phytomedicine. 2008;15;577-586.
36. Volke V, Soosar A, Koks S, Bourin M, Mannisto PT, Vasar E. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolyticlike properties in exploratory models of anxiety. Psychopharmacology. 1997;131:399-405. (Pubitemid 27348707)
37. Yildiz F, Ulak G, Erden BF, Gacar N. Anxiolytic-like effects of 7-Nitroindazole in the rat plus-maze test. Pharmacol Biochem Behav. 2000;65:199-202. (Pubitemid 30100263)
38. Munhoz CD, García-Bueno B, Madrigal JLM, Lepsch LB, Scavone C, Leza JC. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol Res. 2008;41:1037-1046.
39. Thomas MS, Zhang W, Zordan PM, Saragovi HU, Taglialatela G. Signaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cells. J Neuroinflammation. 2005;2:19.
40. Kan W, Zhao KS, Jiang Y, Yan W, Wang J, Quin Q, et al. Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression. Shock. 2004;21:281-287.
41. Grilli M, Memo M. Nuclear factor-κB/Rel proteins. A point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol. 1999;57:1-7.
42. Perkins ND. The Rel/NF-κB family: friend and foe. Trends Biochem Sci. 2000;25:434-440.
43. Schreck G, Meier B, Daniela N, Mannel WD, Patrick AB. Dithiocarbamates as potent inhibitors of nuclear factor KB activation in intact cells. J Exp Med. 1992;175:1181-1194.
44. Kurt M, Bilge SS, Aksoz E, Kukula O, Celik S, Kesim Y. Effect of sildenafill on anxiety in the plus-maze test in mice. Pol J Pharmacol. 2004;56:353-357. (Pubitemid 39010771)
45. Concas A, Mele S, Biggio G. Foot shock stress decreases chloride efflux from rat brain synaptosomes. Eur J Pharmacol. 1987; 135:423-427. (Pubitemid 17057570)
46. Drugan RC, Morrow Al, Weizman R, Weizman A, Deutsch SI, Crawley JN, et al. Stress-induced behavioral depression in the rat is associated with a decresase in GABA receptor mediated chloride ion-flux and brain benzodiazepine receptor occupancy. Brain Res. 1989;487:45-51. (Pubitemid 19135164)
47. Serre M, Concas A, Astogglu T, Biggio G. Stress-like bicuculine and DMCM reduces the basal 36Cl- uptake in the rat cortical membrane vesicles: an effect reversed by GABA. Neurosci Res Commun. 1989;4:41-50. (Pubitemid 19042574)
48. Volke V, Soosaar A, Kõks S, Vasar E, Männistö PT. L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats. Eur J Pharmacol. 1998;351:287-290. (Pubitemid 28321463)
49. Lee JC, Kassis S, Kumar S, Badger A, Adams JL. p38 mitogenactivated protein kinase inhibitors-mechanisms and therapeutic potentials. Pharmacol Ther. 1999;82:389-397. (Pubitemid 29255932)
50. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology. 2000;47:185-201. (Pubitemid 30394538)
51. Baeza-Raja B, Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell. 2004;15:2013-2026. (Pubitemid 38401847)
52. Shimizu N, Yoshiyama M, Omura T, Hanatani A, Kim S, Takeuchi K, et al. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res. 1998;38:116-124. (Pubitemid 28275621)
53. Vercammen E, Staal J, Van Den Broeke A, Haegman M, Vereecke L, Schotte P, et al. Prolonged exposure to IL-1beta and IFNgamma induces necrosis of L929 tumor cells via a p38MAPK/NFkappaB/ NO-dependent mechanism. Oncogene. 2008;27:3780-3788. (Pubitemid 351862060)